Finance

Lists
Why is CTOR up 2.39%?
Dive Deeper
CTOR:NASDAQ
Citius Oncology Inc
$1.07
+2.39%
(+0.025) 1D
Sep 22, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTOR...
Open
$1.00
High
$1.12
Low
$1.00
Mkt. cap
99.02M
Avg. vol.
95.74K
Volume
116.99K
52-wk high
$2.25
52-wk low
$0.49
EPS
-$0.48
Beta
3.53
Shares outstanding
92.98M
Open
$1.00
High
$1.12
Low
$1.00
Mkt. cap
99.02M
Avg. vol.
95.74K
Volume
116.99K
52-wk high
$2.25
52-wk low
$0.49
EPS
-$0.48
Beta
3.53
Shares outstanding
92.98M
About Citius Oncology Inc
CEO-
Employees-
Founded2021
HeadquartersCranford, New Jersey, United States
SectorBiotechnology
Websitecitiusonc.com
Analyst ratings
Based on 1 analyst giving stock ratings to CTOR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CTOR in the last 3 months
Highest
Current $1.07
$4.00 (+273.83%)
Average
$4.00 (+273.83%)
Lowest
$4.00 (+273.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Reiterated
$4.00
+273.8%
08/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
3.94M
1.67M
1.49M
Cost of goods sold
-
789.21K
328.88K
671.34K
Cost of revenue
-
789.21K
328.88K
671.34K
Research and development expenses
1.08M
1.02M
1.08M
218.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.64M
6.82M
27.15M
7.78M
Operating expense
4.71M
8.41M
29.95M
9.72M
Total operating expenses
4.71M
9.20M
30.28M
10.39M
Operating income
-4.71M
-5.25M
-28.61M
-8.90M
Other non operating income
-
-
1.76M
-
EBT including unusual items
-4.73M
-5.27M
-26.84M
-9.03M
EBT excluding unusual items
-4.73M
-5.27M
-26.84M
-9.03M
Income tax expense
264.24K
264.24K
-231.21K
-107.35K
Effective tax rate
-5.58%
-5.01%
0.86%
1.19%
Other operating expenses
-
-
-
-
Net income
-5.00M
-5.53M
-26.61M
-8.92M
Net profit margin
-
-140.31%
-1,595.98%
-597.40%
Earnings per share
-
-
-
-
Interest and investment income
36.37K
28.29K
43.72K
96.85K
Interest expense
-57.28K
-45.84K
-33.03K
-231.73K
Net interest expenses
-20.90K
-17.55K
10.69K
-134.88K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-4.68M
-26.89M
-7.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps